{"id":1934,"date":"2025-11-20T12:02:42","date_gmt":"2025-11-20T18:02:42","guid":{"rendered":"https:\/\/merlinmelanomatest.com\/us\/?page_id=1934"},"modified":"2025-12-01T10:43:31","modified_gmt":"2025-12-01T16:43:31","slug":"merlin_001","status":"publish","type":"page","link":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/","title":{"rendered":"Merlin_001"},"content":{"rendered":"<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-stretch fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-div\" style=\"--awb-margin-bottom:0px;--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:0px;--awb-margin-left-small:0px;--awb-font-size:34px;\"><div class=\"fusion-title-heading title-heading-center title-heading-tag fusion-responsive-typography-calculated\" style=\"font-family:&quot;hero-new&quot;;font-style:normal;font-weight:400;margin:0;font-size:1em;--fontSize:34;line-height:1.8;\">Just Published:<\/div><\/div><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-one\" style=\"--awb-text-color:#e24025;--awb-margin-top:0px;--awb-margin-top-small:0px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><h1 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"font-family:&quot;milibus&quot;;font-style:normal;font-weight:700;margin:0;--fontSize:43;line-height:1.16;\"><span style=\"font-family: milibus,sans-serif;\"><strong>Landmark Melanoma Study <\/strong><\/span><span class=\"break-here\" style=\"font-size: 34px; color: var(--awb-color8);\"><strong>JAMA Surgery<\/strong><\/span><\/h1><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;width:100%;\"><\/div><div class=\"fusion-text fusion-text-1\" style=\"--awb-font-size:22px;\"><p>SkylineDx Publishes Landmark <span style=\"color: var(--awb-color8);\"><strong>MERLIN_001<\/strong><\/span> Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma<\/p>\n<\/div><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-two hero-new\" style=\"--awb-text-color:#e24025;--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-font-size:32px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"font-family:&quot;milibus&quot;;font-style:normal;font-weight:400;margin:0;font-size:1em;--fontSize:32;line-height:1.2;\"><strong>First and only prospective blinded data confirms&#8230;<\/strong><\/h2><\/div><div class=\"fusion-text fusion-text-2\" style=\"--awb-font-size:22px;--awb-margin-left:30px;\"><p>&#8230;the Merlin CP-GEP (Clinico pathological-Gene Expression Profiling) Test accurately stratifies melanoma patients by sentinel node metastasis risk, showing a greater than three-fold difference between High-Risk and Low-Risk groups.<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-background-repeat:repeat;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:20px;--awb-padding-bottom:40px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-stretch fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_3_4 3_4 fusion-flex-column\" style=\"--awb-padding-top:40px;--awb-padding-right:40px;--awb-padding-bottom:0px;--awb-padding-left:40px;--awb-overflow:hidden;--awb-bg-color:var(--awb-custom_color_1);--awb-bg-color-hover:var(--awb-custom_color_1);--awb-bg-size:cover;--awb-border-color:var(--awb-color8);--awb-border-top:2px;--awb-border-right:2px;--awb-border-bottom:2px;--awb-border-left:2px;--awb-border-style:solid;--awb-border-radius:36px 36px 36px 36px;--awb-width-large:75%;--awb-margin-top-large:0px;--awb-spacing-right-large:2.56%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:2.56%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-center fusion-title-text fusion-title-size-three hero-new\" style=\"--awb-text-color:var(--awb-custom14);--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-font-size:32px;\"><h3 class=\"fusion-title-heading title-heading-center fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:32;line-height:1.3;\"><strong>Significant findings among patient sub-groups:<\/strong><\/h3><\/div><ul style=\"--awb-size:18px;--awb-iconcolor:var(--awb-color8);--awb-line-height:30.6px;--awb-icon-width:30.6px;--awb-icon-height:30.6px;--awb-icon-margin:12.6px;--awb-content-margin:43.2px;\" class=\"fusion-checklist fusion-checklist-1 fusion-checklist-default type-icons custom-checkbox-checklist\"><li class=\"fusion-li-item\" style=\"\"><span class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-check fas\" aria-hidden=\"true\"><\/i><\/span><div class=\"fusion-li-item-content\">\n<p>Merlin_001 identified a substantial number of high-risk melanoma patients within the <strong><span style=\"color: #e24025;\">T1 group<\/span><\/strong>, with an SLNB positivity rate of 16.1% (1\/6) &#8211; nearly double the 8.5% risk predicted by clinicopathologic factors alone.<\/p>\n<\/div><\/li><li class=\"fusion-li-item\" style=\"\"><span class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-check fas\" aria-hidden=\"true\"><\/i><\/span><div class=\"fusion-li-item-content\">\n<p>In <strong><span style=\"color: #e24025;\">head and neck melanomas<\/span><\/strong>, the Merlin CP-GEP test identified High-Risk cases with a 26.7% SLN rate and Low-Risk cases with a 4.9% SLN (five-fold risk increase in the High-Risk vs. the Low-Risk groups).<\/p>\n<\/div><\/li><li class=\"fusion-li-item\" style=\"\"><span class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-check fas\" aria-hidden=\"true\"><\/i><\/span><div class=\"fusion-li-item-content\">\n<p>In the subgroup of <strong><span style=\"color: #e24025;\">patients &lt;40 years of age<\/span><\/strong>, the Low-Risk cases showed 0.0% SLN metastases compared with 21.8% in High-Risk cases.<\/p>\n<\/div><\/li><li class=\"fusion-li-item\" style=\"\"><span class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa-check fas\" aria-hidden=\"true\"><\/i><\/span><div class=\"fusion-li-item-content\">\n<p>In patients <span style=\"color: #e24025;\"><strong>aged 65 and older<\/strong><\/span>, where comorbidities can be more prevalent, the test identified 57.9% as High-Risk.<\/p>\n<\/div><\/li><\/ul><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:40px;width:100%;\"><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--link_hover_color: var(--awb-custom14);--link_color: var(--awb-custom13);--awb-background-repeat:repeat;--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:20px;--awb-padding-bottom:60px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-stretch fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"max-width:calc( 1200px + 20px );margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_2_3 2_3 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:66.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-stretch fusion-flex-justify-content-center fusion-flex-content-wrap\" style=\"--awb-flex-grow:0;--awb-flex-grow-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink:0;--awb-flex-shrink-medium:0;--awb-flex-shrink-small:0;width:calc( 100% + 20px ) !important;max-width:calc( 100% + 20px ) !important;margin-left: calc(-20px \/ 2 );margin-right: calc(-20px \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_6 1_6 fusion-flex-column fusion-flex-align-self-stretch\" style=\"--awb-bg-size:cover;--awb-width-large:16.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:16.666666666667%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:20%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-margin-bottom-small:40px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-center fusion-content-layout-column\"><div class=\"fusion-image-element \" style=\"text-align:center;--awb-max-width:82px;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-1 hover-type-none svg\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2840207\" target=\"_blank\" aria-label=\"JAMA-Surgery-SVG-Icon-90&#215;95\" rel=\"noopener noreferrer\"><img decoding=\"async\" width=\"90\" height=\"95\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%2790%27%20height%3D%2795%27%20viewBox%3D%270%200%2090%2095%27%3E%3Crect%20width%3D%2790%27%20height%3D%2795%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/merlinmelanomatest.com\/us\/wp-content\/uploads\/sites\/2\/2025\/11\/JAMA-Surgery-SVG-Icon-90x95-1.svg\" alt class=\"lazyload img-responsive wp-image-2009\"\/><\/a><\/span><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_3 1_3 fusion-flex-column fusion-flex-align-self-stretch\" style=\"--awb-bg-size:cover;--awb-width-large:33.333333333333%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:33.333333333333%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:80%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-center fusion-content-layout-column\"><div class=\"fusion-text fusion-text-3 fusion-text-no-margin\" style=\"--awb-line-height:1.3;--awb-margin-bottom:0px;\"><p><a href=\"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2840207\" target=\"_blank\" rel=\"noopener\">Click Here to Access the Full Publication<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-2 fusion_builder_column_inner_1_6 1_6 fusion-flex-column fusion-flex-align-self-stretch\" style=\"--awb-bg-size:cover;--awb-width-large:16.666666666667%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:16.666666666667%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:20%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-center fusion-content-layout-column\"><div class=\"fusion-image-element \" style=\"text-align:center;--awb-max-width:82px;--awb-caption-title-font-family:var(--h2_typography-font-family);--awb-caption-title-font-weight:var(--h2_typography-font-weight);--awb-caption-title-font-style:var(--h2_typography-font-style);--awb-caption-title-size:var(--h2_typography-font-size);--awb-caption-title-transform:var(--h2_typography-text-transform);--awb-caption-title-line-height:var(--h2_typography-line-height);--awb-caption-title-letter-spacing:var(--h2_typography-letter-spacing);\"><span class=\" fusion-imageframe imageframe-none imageframe-2 hover-type-none svg\"><a class=\"fusion-no-lightbox\" href=\"https:\/\/www.prnewswire.com\/news-releases\/skylinedx-publishes-landmark-merlin001-trial-in-jama-surgery-validating-the-predictive-power-of-the-merlin-cp-gep-test-in-melanoma-302590009.html\" target=\"_blank\" aria-label=\"Press SVG Icon\" rel=\"noopener noreferrer\"><img decoding=\"async\" width=\"90\" height=\"95\" alt=\"Press SVG Icon\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D%27http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%27%20width%3D%2790%27%20height%3D%2795%27%20viewBox%3D%270%200%2090%2095%27%3E%3Crect%20width%3D%2790%27%20height%3D%2795%27%20fill-opacity%3D%220%22%2F%3E%3C%2Fsvg%3E\" data-orig-src=\"https:\/\/merlinmelanomatest.com\/us\/wp-content\/uploads\/sites\/2\/2025\/11\/Press-SVG-Icon.svg\" class=\"lazyload img-responsive wp-image-1951\"\/><\/a><\/span><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-3 fusion_builder_column_inner_1_3 1_3 fusion-flex-column fusion-flex-align-self-stretch\" style=\"--awb-bg-size:cover;--awb-width-large:33.333333333333%;--awb-margin-top-large:0px;--awb-spacing-right-large:10px;--awb-margin-bottom-large:20px;--awb-spacing-left-large:10px;--awb-width-medium:33.333333333333%;--awb-order-medium:0;--awb-spacing-right-medium:10px;--awb-spacing-left-medium:10px;--awb-width-small:80%;--awb-order-small:0;--awb-spacing-right-small:10px;--awb-spacing-left-small:10px;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-center fusion-content-layout-column\"><div class=\"fusion-text fusion-text-4 fusion-text-no-margin\" style=\"--awb-line-height:1.3;--awb-margin-bottom:0px;\"><p><a href=\"https:\/\/www.prnewswire.com\/news-releases\/skylinedx-publishes-landmark-merlin001-trial-in-jama-surgery-validating-the-predictive-power-of-the-merlin-cp-gep-test-in-melanoma-302590009.html\" target=\"_blank\" rel=\"noopener\">Click Here to Access the SkylineDx Press Release<\/a><\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-4 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:40px;--awb-padding-bottom:40px;--awb-padding-top-medium:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-stretch fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-position:center center;--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:9.6%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.84%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:4.8%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:4.8%;--awb-spacing-left-small:1.92%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper lazyload fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column fusion-column-has-bg-image\" data-bg-url=\"https:\/\/merlinmelanomatest.com\/us\/wp-content\/uploads\/sites\/2\/2021\/09\/about-us-researchers.jpg\" data-bg=\"https:\/\/merlinmelanomatest.com\/us\/wp-content\/uploads\/sites\/2\/2021\/09\/about-us-researchers.jpg\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row fusion-flex-align-items-stretch fusion-flex-content-wrap\" style=\"--awb-flex-grow:0;--awb-flex-grow-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink:0;--awb-flex-shrink-medium:0;--awb-flex-shrink-small:0;width:104% !important;max-width:104% !important;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-4 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.84%;--awb-width-medium:25%;--awb-order-medium:0;--awb-spacing-right-medium:7.68%;--awb-spacing-left-medium:7.68%;--awb-width-small:16.666666666667%;--awb-order-small:0;--awb-spacing-right-small:11.52%;--awb-spacing-left-small:11.52%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-5 fusion_builder_column_inner_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:3.84%;--awb-width-medium:75%;--awb-order-medium:0;--awb-spacing-right-medium:2.56%;--awb-spacing-left-medium:2.56%;--awb-width-small:83.333333333333%;--awb-order-small:0;--awb-spacing-right-small:2.304%;--awb-spacing-left-small:2.304%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><\/div><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:40%;width:100%;\"><\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_2 1_2 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:50%;--awb-margin-top-large:0px;--awb-spacing-right-large:3.84%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:9.6%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:4.8%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:4.8%;\" data-scroll-devices=\"small-visibility,medium-visibility,large-visibility\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-text-color:#e24025;--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:40;line-height:1.2;\"><strong>Contact<\/strong><\/h2><\/div><div class=\"fusion-text fusion-text-5\" style=\"--awb-font-size:22px;--awb-text-transform:none;\"><p>Please contact us with any questions you may have.<\/p>\n<\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;width:100%;\"><\/div><div class=\"fusion-text fusion-text-6\" style=\"--awb-font-size:22px;--awb-text-transform:none;\"><p>Phone: 858-886-7907<br \/>\nFax: 858-258-5188<\/p>\n<\/div><div class=\"fusion-text fusion-text-7\" style=\"--awb-font-size:22px;\"><p><a class=\"autolinked\" href=\"mailto:clientservices@skylinedx.com\" target=\"_blank\" rel=\"noopener noreferrer\" data-behavior=\"truncate\">clientservices@skylinedx.com<\/a><\/p>\n<\/div><\/div><\/div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-order-medium:0;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-order-small:0;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"open","template":"100-width.php","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-1934","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merlin Melanoma<\/title>\n<meta name=\"description\" content=\"Merlin is a powerful tool in personalized melanoma care.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merlin Melanoma\" \/>\n<meta property=\"og:description\" content=\"Merlin is a powerful tool in personalized melanoma care.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/\" \/>\n<meta property=\"og:site_name\" content=\"Merlin US\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-01T16:43:31+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/merlin_001\\\/\",\"url\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/merlin_001\\\/\",\"name\":\"Merlin Melanoma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/#website\"},\"datePublished\":\"2025-11-20T18:02:42+00:00\",\"dateModified\":\"2025-12-01T16:43:31+00:00\",\"description\":\"Merlin is a powerful tool in personalized melanoma care.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/merlin_001\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/merlin_001\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/merlin_001\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merlin_001\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/\",\"name\":\"Merlin US\",\"description\":\"A powerful tool in personalized melanoma care\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merlin Melanoma","description":"Merlin is a powerful tool in personalized melanoma care.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/","og_locale":"en_US","og_type":"article","og_title":"Merlin Melanoma","og_description":"Merlin is a powerful tool in personalized melanoma care.","og_url":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/","og_site_name":"Merlin US","article_modified_time":"2025-12-01T16:43:31+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/","url":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/","name":"Merlin Melanoma","isPartOf":{"@id":"https:\/\/merlinmelanomatest.com\/us\/#website"},"datePublished":"2025-11-20T18:02:42+00:00","dateModified":"2025-12-01T16:43:31+00:00","description":"Merlin is a powerful tool in personalized melanoma care.","breadcrumb":{"@id":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/merlinmelanomatest.com\/us\/merlin_001\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/merlinmelanomatest.com\/us\/merlin_001\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/merlinmelanomatest.com\/us\/"},{"@type":"ListItem","position":2,"name":"Merlin_001"}]},{"@type":"WebSite","@id":"https:\/\/merlinmelanomatest.com\/us\/#website","url":"https:\/\/merlinmelanomatest.com\/us\/","name":"Merlin US","description":"A powerful tool in personalized melanoma care","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/merlinmelanomatest.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/1934","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/comments?post=1934"}],"version-history":[{"count":71,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/1934\/revisions"}],"predecessor-version":[{"id":2014,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/1934\/revisions\/2014"}],"wp:attachment":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/media?parent=1934"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}